Target intelligence / Profile preview

Dystrophia Myotonica Protein Kinase (DMPK)

Target
DMPK
Molecular classification
Enzyme, Protein Kinase, Serine/threonine-protein kinase, AGC family kinase
01

Overview

Dystrophia myotonica protein kinase (DMPK) is a serine/threonine-specific protein kinase that plays a crucial role in muscle, heart, and brain cells. It is encoded by the DMPK gene and is most notable for its involvement in the pathogenesis of myotonic dystrophy type 1 (DM1). DMPK acts as a non-receptor serine/threonine protein kinase essential for maintaining skeletal muscle structure and function. It regulates intracellular communication and modulates the production/function of key structures inside muscle cells. DM1 results from an unstable CTG trinucleotide repeat expansion within the DMPK gene, leading to toxic RNA species that disrupt normal cellular function. Decreased expression or loss-of-function mutations can contribute directly to disease pathology.

Other names
Myotonic dystrophy protein kinaseMyotonin-protein kinase
02

Mechanism of action

Modulation of pathways affected by toxic RNA foci generated from mutant transcripts; Inhibition of myosin phosphatase

03

Biological functions

Muscle maintenanceRegulation of contraction-relaxation cycleIntracellular communicationSignal transductionRegulation of cytoskeletal organization
04

Disease associations

Myotonic dystrophy type 1
05

Safety considerations

Potential for off-target effects due to kinase family conservationChallenges in specifically targeting mutant DMPK without affecting wild-type function
06

Biomarkers

CTG repeat length in DMPK geneDNA methylation status at DMPK locus

Beyond the preview

Go deeper on Dystrophia Myotonica Protein Kinase (DMPK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophia Myotonica Protein Kinase (DMPK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call